Chemoimmunotherapy with modified dosing of fludarabine, cyclophosphamide, and rituximab shows significant clinical activity in patients with previously untreated chronic lymphocytic leukemia.
Lamanna
Nicole
N
Leukemia Service at Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
Weiss
Mark A
MA